Assembly Biosciences, Inc. (ASMB) Financial Statements (2024 and earlier)

Company Profile

Business Address 331 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments91,610146,627216,413274,043218,080119,948
Cash and cash equivalents52,41845,62759,44446,73241,47182,033
Short-term investments39,192101,000156,969227,311176,60937,914
Receivables 9443361,2303,3742,4302,273
Other undisclosed current assets4,4137,2416,8505,3631,992897
Total current assets:96,967154,204224,493282,780222,502123,119
Noncurrent Assets
Operating lease, right-of-use asset3,1956,0429,13111,975
Property, plant and equipment7431,1391,6001,830557860
Long-term investments and receivables  27,972   3,347
Long-term investments  27,972   3,347
Intangible assets, net (including goodwill)   41,63841,63841,63841,638
Goodwill   12,63812,63812,63812,638
Intangible assets, net (excluding goodwill)   29,00029,00029,00029,000
Other noncurrent assets8891,7036,3921,6843,348 
Other undisclosed noncurrent assets      340
Total noncurrent assets:4,82736,85658,76157,12745,54346,185
TOTAL ASSETS:101,794191,060283,254339,907268,045169,303
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,8109,52216,58510,0179,6796,139
Accounts payable2,4932,6594,5981,731  
Accrued liabilities7,3176,86311,9878,2869,6796,139
Deferred revenue    6,411
Debt    3,186  
Deferred revenue and credits5,229
Deferred tax liabilities3,252 
Other undisclosed current liabilities6,4866,5517,8484,8265,5412,124
Total current liabilities:16,29616,07324,43324,44018,47213,492
Noncurrent Liabilities
Long-term debt and lease obligation:  3,3256,7259,082  
Liabilities, other than long-term debt2,8342,73311,51833,16810840,556
Deferred revenue and credits40,556
Deferred revenue2,7332,7338,98730,637
Deferred rent credit     108
Deferred income tax liabilities   2,5312,531
Operating lease, liability1013,3256,7259,082
Other undisclosed noncurrent liabilities     38,8122,136
Total noncurrent liabilities:2,8346,05818,24342,25038,92042,692
Total liabilities:19,13022,13142,67666,69057,39256,184
Equity
Equity, attributable to parent82,664168,929240,578273,217210,653113,120
Common stock494834322520
Additional paid in capital807,938800,728742,387712,807552,762364,528
Accumulated other comprehensive loss(803)(419)(270)(201)(347)(392)
Accumulated deficit(724,520)(631,428)(501,573)(439,421)(341,787)(251,036)
Total equity:82,664168,929240,578273,217210,653113,120
TOTAL LIABILITIES AND EQUITY:101,794191,060283,254339,907268,045169,303

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1536,25479,10515,96314,8049,019
Revenue, net9,019
Sublease income 153142  
Cost of revenue
(Cost of Goods and Services Sold)
      (4,600)
Gross profit: 1536,25479,10515,96314,8044,419
Operating expenses(94,114)(138,942)(143,881)(118,676)(107,539)(61,246)
Other undisclosed operating income (loss) (153)    4,600
Operating loss:(94,114)(132,688)(64,776)(102,713)(92,735)(52,227)
Nonoperating income1,0223022,6244,3053,083368
Investment income, nonoperating     229208
Loss from continuing operations before income taxes:(93,092)(132,386)(62,152)(98,408)(89,652)(51,859)
Income tax expense (benefit)  2,531 774(1,099)9,050
Loss from continuing operations:(93,092)(129,855)(62,152)(97,634)(90,751)(42,809)
Loss before gain (loss) on sale of properties:(129,855)(62,152)(97,634)(90,751)(42,809)
Net loss available to common stockholders, diluted:(93,092)(129,855)(62,152)(97,634)(90,751)(42,809)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(93,092)(129,855)(62,152)(97,634)(90,751)(42,809)
Other comprehensive loss      (149)
Comprehensive loss:(93,092)(129,855)(62,152)(97,634)(90,751)(42,957)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(384)(149)(69)14645357
Comprehensive loss, net of tax, attributable to parent:(93,476)(130,004)(62,221)(97,488)(90,706)(42,600)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: